Keith Wilson
Faculty Member
Last active: 12/25/2019

  1. Immune evasion by Helicobacter pylori is mediated by induction of macrophage arginase II. Lewis ND, Asim M, Barry DP, de Sablet T, Singh K, Piazuelo MB, Gobert AP, Chaturvedi R, Wilson KT (2011) J Immunol 186(6): 3632-41
    › Primary publication · 21296975 (PubMed) · PMC3069806 (PubMed Central)
  2. Disruption of nitric oxide signaling by Helicobacter pylori results in enhanced inflammation by inhibition of heme oxygenase-1. Gobert AP, Asim M, Piazuelo MB, Verriere T, Scull BP, de Sablet T, Glumac A, Lewis ND, Correa P, Peek RM, Chaturvedi R, Wilson KT (2011) J Immunol 187(10): 5370-9
    › Primary publication · 21987660 (PubMed) · PMC3208050 (PubMed Central)
  3. Difluoromethylornithine is a novel inhibitor of Helicobacter pylori growth, CagA translocation, and interleukin-8 induction. Barry DP, Asim M, Leiman DA, de Sablet T, Singh K, Casero RA, Chaturvedi R, Wilson KT (2011) PLoS One 6(2): e17510
    › Primary publication · 21386987 (PubMed) · PMC3046249 (PubMed Central)
  4. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. Yan F, Cao H, Cover TL, Washington MK, Shi Y, Liu L, Chaturvedi R, Peek RM, Wilson KT, Polk DB (2011) J Clin Invest 121(6): 2242-53
    › Primary publication · 21606592 (PubMed) · PMC3104743 (PubMed Central)
  5. Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation. Dhawan P, Ahmad R, Chaturvedi R, Smith JJ, Midha R, Mittal MK, Krishnan M, Chen X, Eschrich S, Yeatman TJ, Harris RC, Washington MK, Wilson KT, Beauchamp RD, Singh AB (2011) Oncogene 30(29): 3234-47
    › Primary publication · 21383692 (PubMed) · PMC3591522 (PubMed Central)
  6. Cationic amino acid transporter 2 enhances innate immunity during Helicobacter pylori infection. Barry DP, Asim M, Scull BP, Piazuelo MB, de Sablet T, Lewis ND, Coburn LA, Singh K, Ellies LG, Gobert AP, Chaturvedi R, Wilson KT (2011) PLoS One 6(12): e29046
    › Primary publication · 22194986 (PubMed) · PMC3237590 (PubMed Central)
  7. Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Peek RM, Fiske C, Wilson KT (2010) Physiol Rev 90(3): 831-58
    › Primary publication · 20664074 (PubMed) · PMC2990353 (PubMed Central)
  8. Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer. Schneider BG, Peng DF, Camargo MC, Piazuelo MB, Sicinschi LA, Mera R, Romero-Gallo J, Delgado AG, Bravo LE, Wilson KT, Peek RM, Correa P, El-Rifai W (2010) Int J Cancer 127(11): 2588-97
    › Primary publication · 20178103 (PubMed) · PMC2916942 (PubMed Central)
  9. Polyamines Impair Immunity to Helicobacter pylori by Inhibiting L-Arginine Uptake Required for Nitric Oxide Production. Chaturvedi R, Asim M, Hoge S, Lewis ND, Singh K, Barry DP, de Sablet T, Piazuelo MB, Sarvaria AR, Cheng Y, Closs EI, Casero RA, Gobert AP, Wilson KT (2010) Gastroenterology 139(5): 1686-98, 1698.e1-6
    › Primary publication · 20600019 (PubMed) · PMC2967614 (PubMed Central)
  10. Pathology of gastric intestinal metaplasia: clinical implications. Correa P, Piazuelo MB, Wilson KT (2010) Am J Gastroenterol 105(3): 493-8
    › Primary publication · 20203636 (PubMed) · PMC2895407 (PubMed Central)